Or an athlete?
If you are looking for some inspiration for the day, watch an excerpt from the 2009 Sports documentary movie “Athlete.” It is a movie outtake featuring Hodgkin's lymphoma cancer survivor, Jenny, discussing what defines an athlete. Jenny completed Ironman Lake Placid.
For more information on the movie, which features four athletes – everyday athletes in America. Besides Jenny, there is a blind man and two win sisters training for a marathon.
ATHLETE is directed by David Lam, an award-winning creative manager for a leading Internet company in NYC. The idea for the documentary ATHLETE came from his experience in completing five marathons in New York, London, Chicago, and San Francisco.
For more information, go to http://athletemovie.com/. One of the cool things he’s doing is creating a Cycle of Giving so fans can buy powerful posters from the movie stills and give back to charities mentioned in the movie.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...